trial · primary record
Mitapivat
Pediatric Pyruvate Kinase Deficiency
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 49 |
| Primary completion | 2029-06 |
| Primary endpoint | Percentage of Participants Achieving Transfusion Reduction Response (TRR) |
| Registry ID | NCT05144256 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:49.446Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05144256
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mitapivat · compound